dallas tx 7/1/2010 11:00:23 PM
News / Business

Top Penny Stock Gainers Today include NUEC, SREH, ARNA

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

Active Penny Stocks in the News

 

PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.

 

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

 

NuEarth Corporation (Pink Sheets: NUEC) reached up 11.11% in morning trading to $.10 with 1M shares traded. NuEarth Corporation (Pink Sheets: NUEC) (" NuEarth "), a manufacturer and marketer of "Clean & Green" products and technology, today announced that the company's Laboratory and Research Division "TerraSolv SA" has received final approval for Phase Three of their long term contract representing an additional $1,650,000 laboratory service contract with the Nigerian National Petroleum Corporation (NNPC) and their subsidiary the Integrated Data Services Limited (IDSL).

For detailed quote and full article http://www.pennytrader.com/quotes/NUEC.php

 

Strategic Rare Earth Metals (Pink sheets: SREH) was up 20% in morning trading to $.0012 with 30M shares traded. Strategic Rare Earth is the parent company of two subsidiaries, Mobile2Earth and Scientific News International. It offers end-to-end iPhone application development services including iPhone app concept development, actual app development and app marketing and promotion. SRE CEO, Tony Dibiase, announces today that SRE subsidiary, Mobile2Earth (www.mobile2earth.com), has been approved by Apple for the Apple Developer Connection (ADC), which gives M2E access to a complete and integrated process for developing and distributing applications for iPad, iPhone, and iPod touch.

For detailed quote and full article http://www.pennytrader.com/quotes/SREH.php

 

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) was up 11.40% in morning trading to $3.42 with 5M shares traded. Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena Pharmaceuticals, Inc. (Nasdaq: ARNA - News) today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.

For detailed quote and full article http://www.pennytrader.com/quotes/ARNA.php

 

Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/

 

About PennyTrader.com

 

PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.

 

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report

For complete disclosure information go to http://www.pennytrader.com/disclosure/

 

PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/